Vijaya Diagnostic Centre Limited has informed the Exchange regarding Appointment of M/s Santhosh & Associates, Cost Accountants as Cost Auditors of the Company for FY2025-26 w.e.f. May 12, 2025.
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vijaya Diagnostic Centre's board, meeting on May 12, 2025, approved audited standalone and consolidated results for Q4 and FY ending March 31, 2025, with statutory auditors issuing an 'Unmodified Opinion.' The board recommended a final dividend of ₹2 per share (200% on face value of ₹1), subject to shareholder approval at the upcoming AGM. Mr. S. Ramachandra Reddy, currently General Manager – Finance, was appointed as Interim CFO and Key Managerial Personnel, while Mr. Lanka Sai Srinivas (ex-UnitedHealth Group, Wipro) was appointed as Chief Technology Officer. M/s Santhosh & Associates were re-appointed as Cost Auditors for FY2025-26. The Nomination and Remuneration Committee also granted 1,91,150 ESOPs at ₹815 per option (a 20% discount on the 3-month average closing price) under the VDCL ESOP Plan 2018.
Shareholders get a clean audit, a 200% final dividend, and fresh senior leadership (Interim CFO, CTO) alongside an ESOP grant that aligns employee interests. The 'interim' tag on the CFO role suggests a permanent replacement is still being searched for, which is a point to watch for future disclosures.